mTOR signaling in renal ion transport
Acta Physiologica · 2023
DOI: 10.1111/apha.13960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Physiologica, 2023. Verfasst von Anastasia Adella und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Acute Kidney Injury, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The mammalian target of rapamycin (mTOR) signaling pathway is crucial in maintaining cell growth and metabolism. The mTOR protein kinase constitutes the catalytic subunit of two multimeric protein complexes called mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). As such, this pathway is indispensable for many organs, including the kidney. Since its discovery, mTOR has been associated with major renal disorders such as acute kidney injury, chronic kidney disease, and polycystic kidney disease. On top of that, emerging studies using pharmacological interventions and genetic disease models have unveiled mTOR role in renal tubular ion handling. Along the tubule, mTORC1 and mTORC2 subunits are ubiquitously expressed at mRNA level. Nevertheless, at the protein level, current studies suggest that a tubular segment‐specific balance between mTORC1 and mTORC2 exists. In the proximal tubule, mTORC1 regulates nutrients transports through various transporters located in this segment. On the other hand, in the thick ascending limb of the loop of Henle, both complexes play a role in regulating NKCC2 expression and activity. Lastly, in the principal cells of the collecting duct, mTORC2 determines Na + reabsorption and K + excretion by regulating of SGK1 activation. Altogether, these studies establish the relevance of the mTOR signaling pathway in the pathophysiology of tubular solute transport. Despite extensive studies on the effectors of mTOR, the upstream activators of mTOR signaling remain elusive in most nephron segments. Further understanding of the role of growth factor signaling and nutrient sensing is essential to establish the exact role of mTOR in kidney physiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Anastasia Adella, Jeroen H F de Baaij
Förderung
- H2020 European Research Council
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Adella, A., & de Baaij, J. H. F. (2023). mTOR signaling in renal ion transport. Acta Physiologica. https://doi.org/10.1111/apha.13960
Vancouver
Adella A, de Baaij JHF. mTOR signaling in renal ion transport. Acta Physiologica. 2023. doi:10.1111/apha.13960
BibTeX
@article{Adella2023,
author = {Adella, Anastasia and de Baaij, Jeroen H F},
title = {mTOR signaling in renal ion transport},
journal = {Acta Physiologica},
year = {2023},
doi = {10.1111/apha.13960}
}
EUVIMED